X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (989) 989
Dissertation (64) 64
Conference Proceeding (63) 63
Publication (56) 56
Patent (43) 43
Paper (37) 37
Book Chapter (10) 10
Book / eBook (2) 2
Report (2) 2
Technical Report (2) 2
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (211) 211
male (151) 151
gastroenterology & hepatology (144) 144
index medicus (139) 139
female (134) 134
middle aged (113) 113
aged (105) 105
adult (80) 80
animals (76) 76
physics (67) 67
gastroenterology and hepatology (66) 66
oncology (58) 58
analysis (57) 57
cancer (53) 53
gastroenterology (52) 52
hepatology (45) 45
mice (45) 45
aged, 80 and over (40) 40
experiment (38) 38
japan (38) 38
expression (37) 37
medicine & public health (37) 37
particle physics (37) 37
biopsy (35) 35
fibrosis (35) 35
rats (35) 35
biochemistry & molecular biology (34) 34
fatty liver (34) 34
hepatocellular carcinoma (32) 32
high energy physics - experiment (31) 31
care and treatment (30) 30
research (29) 29
oxidative stress (28) 28
steatohepatitis (28) 28
tumors (28) 28
hepatitis c (27) 27
liver (26) 26
physics - high energy physics - experiment (26) 26
fysik (25) 25
health aspects (25) 25
liver - pathology (25) 25
physical sciences (25) 25
natural sciences (24) 24
naturvetenskap (24) 24
optics (24) 24
risk factors (24) 24
surgical oncology (24) 24
treatment outcome (24) 24
colorectal surgery (23) 23
interferon (23) 23
liver cancer (23) 23
infection (22) 22
medical colleges (22) 22
medical research (22) 22
medicine (22) 22
retrospective studies (22) 22
colorectal cancer (21) 21
corrosion (21) 21
development and progression (21) 21
endoscopy (21) 21
hepatitis (21) 21
insulin-resistance (21) 21
non-alcoholic fatty liver disease (21) 21
surgery (21) 21
diagnosis (20) 20
gene expression (20) 20
liver diseases (20) 20
proteins (20) 20
abdominal surgery (19) 19
cells (19) 19
chemotherapy (19) 19
cirrhosis (19) 19
hepatocellular-carcinoma (19) 19
medicine, experimental (19) 19
multidisciplinary sciences (19) 19
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (18) 18
association (18) 18
cell line (18) 18
cell line, tumor (18) 18
high energy physics (18) 18
prognosis (18) 18
rna (18) 18
subatomic physics (18) 18
subatomär fysik (18) 18
time factors (18) 18
accelerated exposure test (17) 17
amino acid sequence (17) 17
carcinoma, hepatocellular - genetics (17) 17
chronic hepatitis c (17) 17
disease (17) 17
genetic aspects (17) 17
risk (17) 17
studies (17) 17
alanine transaminase - blood (16) 16
amino acids (16) 16
biophysics (16) 16
dna (16) 16
genes (16) 16
hepatitis c virus (16) 16
internal medicine (16) 16
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1069) 1069
Japanese (86) 86
French (16) 16
Korean (11) 11
German (5) 5
Chinese (4) 4
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Health-System Pharmacy, ISSN 1079-2082, 02/2016, Volume 73, Issue 4, p. 186
Journal Article
1998, 1st ed., ISBN 9780080433202, 447
The near-field earthquake which struck the Hanshin-Awaji area of Japan before dawn on January 17, 1995, in addition to snatching away the lives of more than... 
Structural frames | Building, Iron and steel | Structural stability | Steel | Ductility | Civil Engineering, Surveying & Building
eBook
Journal of Gastroenterology, ISSN 0944-1174, 1/2018, Volume 53, Issue 1, pp. 140 - 151
We aimed to investigate the efficacy of canagliflozin (based on its effect on liver function and blood glucose levels) and its safety in high alanine... 
Medicine & Public Health | Canagliflozin | Colorectal Surgery | Hepatology | Japan | Gastroenterology | Abdominal Surgery | Alanine aminotransferase | Type 2 diabetes mellitus | Surgical Oncology | Hepatic function | VISCERAL FAT | EFFICACY | SAFETY | FATTY LIVER-DISEASE | 52-WEEK OPEN-LABEL | NONALCOHOLIC STEATOHEPATITIS | PREVALENCE | INSULIN-RESISTANCE | DOUBLE-BLIND | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | Canagliflozin - administration & dosage | Liver Function Tests | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Canagliflozin - pharmacology | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Body Weight - drug effects | Male | Canagliflozin - adverse effects | Hypoglycemic Agents - pharmacology | Randomized Controlled Trials as Topic | Blood Glucose - drug effects | Hypoglycemic Agents - administration & dosage | Sodium-Glucose Transporter 2 Inhibitors - administration & dosage | Adult | Female | Aged | Liver Diseases - drug therapy | Liver Diseases - physiopathology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Medical research | Blood sugar | Liver | Clinical trials | Glycosylated hemoglobin | Medicine, Experimental | Alanine | Diabetes mellitus | Body weight | Hemoglobin | Alanine transaminase | Glucose | Diabetes
Journal Article
Journal of Hepatology, ISSN 0168-8278, 04/2019, Volume 70, Issue 1, pp. e380 - e380
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 1/2011, Volume 46, Issue 1, pp. 101 - 107
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 01/2012, Volume 12, Issue 1, pp. 2 - 2
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2017, Volume 52, Issue 4, pp. 520 - 533
Elbasvir (EBR) in combination with grazoprevir (GZR) has demonstrated efficacy in patients with hepatitis C virus (HCV) infections in trials primarily... 
Therapy | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Clinical trial | Genotype | Efficacy | Surgical Oncology | Sustained virologic response | MK-8742 | MK-5172 | OPEN-LABEL | RIBAVIRIN | TRIAL | TREATMENT-NAIVE | HEPATITIS-C VIRUS | CIRRHOSIS | GENOTYPE 1 INFECTION | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | Quinoxalines - adverse effects | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | RNA, Viral - blood | Benzofurans - blood | Hepatitis C, Chronic - complications | Quinoxalines - blood | Young Adult | Aged, 80 and over | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Quinoxalines - therapeutic use | Hepacivirus - drug effects | Hepacivirus - isolation & purification | Liver Cirrhosis - drug therapy | Benzofurans - therapeutic use | Double-Blind Method | Drug Administration Schedule | Quinoxalines - administration & dosage | Administration, Oral | Antiviral Agents - blood | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Benzofurans - adverse effects | Hepatitis C, Chronic - blood | Imidazoles - blood | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | Aged | Sustained Virologic Response | Medicine, Experimental | Clinical trials | Medical research | Hepatitis C virus | Health aspects | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Cancer Science, ISSN 1347-9032, 01/2017, Volume 108, Issue 1, pp. 81 - 90
The aim of this research was to investigate the correlation of immunologic factors in the tumor environment of breast cancer, using immunohistological staining... 
programmed death ligand 1 | phosphatase and tensin homolog | Early stage breast cancer | programmed death 1 | tumor infiltrating lymphocytes | SURVIVAL | PEPTIDE VACCINATION | MACROPHAGES | PTEN | INFILTRATING DUCTAL CARCINOMA | B7-H1 PD-L1 | ONCOLOGY | POOR-PROGNOSIS | EXPRESSION | T-CELLS | LYMPHOCYTES | Prognosis | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Tumor Microenvironment | Antigens, CD - metabolism | Aged, 80 and over | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Lymphocytes, Tumor-Infiltrating - cytology | Japan | Proportional Hazards Models | PTEN Phosphohydrolase - metabolism | Programmed Cell Death 1 Receptor - metabolism | Receptors, Cell Surface - metabolism | Treatment Outcome | CD3 Complex - metabolism | B7-H1 Antigen - metabolism | CD8 Antigens - metabolism | Macrophages - metabolism | Breast Neoplasms - pathology | Antigens, Differentiation, Myelomonocytic - metabolism | Aged | Neoplasm Staging | Medical research | Phosphatases | Analysis | Medicine, Experimental | Breast cancer | Macrophages | Immunity | Tensin | Automation | CD8 antigen | CD3 antigen | Metastasis | Patients | ErbB-2 protein | Clinical outcomes | Metastases | Studies | CD163 antigen | Chemotherapy | Epidermal growth factor | Immunology | Lymphocytes | Medical prognosis | Surgery | PTEN protein | Original
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2017, Volume 85, Issue 5, pp. AB525 - AB526
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 11/2014, Volume 49, Issue 11, pp. 1477 - 1484
The prevalence of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome have been increasing worldwide. The associations between metabolic factors... 
NAFLD | Medicine & Public Health | Colorectal Surgery | Hepatology | Diabetes mellitus | Gastroenterology | Abdominal Surgery | Histology | Retrospective study | Surgical Oncology | METABOLIC SYNDROME | FOLLOW-UP | PREVALENCE | NATURAL-HISTORY | HEPATOCELLULAR-CARCINOMA | CLINICAL SCORING SYSTEM | INSULIN-RESISTANCE | CIRRHOSIS | GLUCOSE | STEATOHEPATITIS | GASTROENTEROLOGY & HEPATOLOGY | Liver Cirrhosis - ethnology | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Prevalence | Age Factors | Dyslipidemias - complications | Humans | Middle Aged | Male | Non-alcoholic Fatty Liver Disease - ethnology | Diabetes Mellitus, Type 2 - epidemiology | Non-alcoholic Fatty Liver Disease - complications | Adult | Female | Retrospective Studies | Hypertension - epidemiology | Diabetes Mellitus, Type 2 - complications | Severity of Illness Index | Liver Cirrhosis - etiology | Cross-Sectional Studies | Obesity - complications | Japan | Risk Factors | Logistic Models | Asian Continental Ancestry Group | Dyslipidemias - epidemiology | Biopsy | Obesity - epidemiology | Hypertension - complications | Liver Cirrhosis - pathology | Aged | Type 2 diabetes | Hypertension | Glucose metabolism | Care and treatment | Fatty liver | Low density lipoproteins | Analysis | Fibrosis | Postmenopausal women | Glucose | Risk factors | Dextrose
Journal Article
Journal of Hepatology, ISSN 0168-8278, 04/2019, Volume 70, Issue 1, pp. e309 - e309
Journal Article